|
WTAP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.220400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.016700E-04 |
| Normal-vs-Stage2 |
3.200000E-01 |
| Normal-vs-Stage3 |
7.170000E-02 |
| Normal-vs-Stage4 |
9.311500E-02 |
| Stage1-vs-Stage2 |
2.359800E-01 |
| Stage1-vs-Stage3 |
2.423400E-01 |
| Stage1-vs-Stage4 |
4.177000E-01 |
| Stage2-vs-Stage3 |
7.596600E-01 |
| Stage2-vs-Stage4 |
6.931400E-01 |
| Stage3-vs-Stage4 |
8.703000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.877010E-03 |
| Normal-vs-AfricanAmerican |
5.319200E-01 |
| Normal-vs-Asian |
6.561000E-01 |
| Caucasian-vs-AfricanAmerican |
1.546790E-01 |
| Caucasian-vs-Asian |
6.244200E-01 |
| AfricanAmerican-vs-Asian |
9.422800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.521500E-02 |
| Normal-vs-Female |
2.565500E-04 |
| Male-vs-Female |
3.533700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.158200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.161500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.454240E-02 |
| Normal-vs-Age(81-100Yrs) |
2.651800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.704600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.478200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.742600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.155000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.614600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.258800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.719900E-03 |
| Normal-vs-Grade 2 |
1.966210E-04 |
| Normal-vs-Grade 3 |
1.715160E-01 |
| Normal-vs-Grade 4 |
1.208770E-01 |
| Grade 1-vs-Grade 2 |
3.887200E-01 |
| Grade 1-vs-Grade 3 |
5.916200E-02 |
| Grade 1-vs-Grade 4 |
2.338800E-01 |
| Grade 2-vs-Grade 3 |
6.884700E-03 |
| Grade 2-vs-Grade 4 |
2.676600E-01 |
| Grade 3-vs-Grade 4 |
4.997800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.65799999995997E-06 |
| Normal-vs-ccB subtype |
2.350800E-01 |
| ccA subtype-vs-ccB subtype |
2.411500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.601700E-04 |
| Normal-vs-N1 |
3.850600E-01 |
| N0-vs-N1 |
9.253600E-01 |
|
|
